- Advertisement -

Lixte Biotechnology and City of Hope Enroll First Patient in Phase 1b Trial of Lead Compound – GlobeNewswire

Extensive preclinical data shows LB-100 increases the effectiveness of chemotherapy in animal modelsDue to the aggressive progression of small cell lung cancer, it is...

Researchers study effects of solvation and ion valency on metallopolymers

In a new paper published in JACS AU, researchers at the University of Illinois Urbana-Champaign analyzed the effects of solvation and ion valency on...

Redefining Cell and Gene Therapy Navigation

View eBook   Making the right choices in manufacturing and testing early-on is critical for gaining regulatory approval and achieving patient access faster. Charles River’s suite...

Inscripta Reports Successful Scaleup of an Anti-Aging Skincare Ingredient

Officials at Inscripta say they successfully completed scale-up runs and are moving into commercial manufacturing of an anti-aging skincare ingredient. Commercial biomanufacturing addresses serious challenges...

Microcone-enhanced microfluidic device captures circulating tumor cells efficiently

Circulating tumor cells (CTCs) refer to cancer cells that have broken off from a primary tumor. These tumor cells can travel through the blood...

Vector BioPharma and iBET collaborate to develop high-throughput analytical methods and...

Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients,...

Bio-Techne, Refeyn Partner on Workflow for Bispecific Antibody, Biosimilar Characterization

This week, Bio-Techne, a provider of life science tools, reagents, and diagnostic product, and Refeyn, a pioneer in mass photometry technology, announced the launch...

Immune Cell Phenotyping: Cell Surface Architecture Informs Disease Biology

Register Now Erdinc Sezgin, PhD Senior LecturerKarolinska Institutet View Bio ...

Bio-Techne, Refeyn Partner on Workflow for Bispecific Antibody, Biosimilar Characterization

This week, Bio-Techne, a provider of life science tools, reagents, and diagnostic product, and Refeyn, a pioneer in mass photometry technology, announced the launch...

Immune Cell Phenotyping: Cell Surface Architecture Informs Disease Biology

Register Now Erdinc Sezgin, PhD Senior LecturerKarolinska Institutet View Bio ...

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat...

more new items

Bio-Techne, Refeyn Partner on Workflow for Bispecific Antibody, Biosimilar Characterization

This week, Bio-Techne, a provider of life science tools, reagents, and diagnostic product, and Refeyn, a pioneer in mass photometry technology, announced the launch...

Immune Cell Phenotyping: Cell Surface Architecture Informs Disease Biology

Register Now Erdinc Sezgin, PhD Senior LecturerKarolinska Institutet View Bio ...

Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney...

Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat...